Clinical Trial Update: Efficacy of Biosimilar Filgrastim on the Mobilization of Hematopoietic Stem Cell CD34+ (Cluster of Differentiation 34) and on the Kinetic Engraftment

View source ↗

Summary

This clinical trial update reports on the efficacy of a biosimilar filgrastim for mobilizing CD34+ hematopoietic stem cells and its impact on engraftment kineti…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hematologic Diseases

Drugs mentioned

• Filgrastim (biosimilar) (filgrastim)

Snippet

Sponsor: Azienda Ospedaliera San Giovanni Battista | Conditions: Blood Diseases | Status: UNKNOWN